Nerai Bioscience

Biotechnology Research • Dorfstrasse, Zurich, Switzerland • 1-10 Employees

Company overview

Headquarters	Dorfstrasse, Zurich, Switzerland
Website	nerai.bio
NAICS	541714
Employees	1-10
Socials

Key Contacts at Nerai Bioscience

Vincent Forster

Ceo And Co-Founder

Gerald Schwank

Co-Founder

Sasha Melkonyan

Co-Founder

Lukas Schmidheini

Co-Founder

Nerai Bioscience Email Formats

Nerai Bioscience uses 2 email formats. The most common is {first initial} (e.g., j@nerai.bio), used 50% of the time.

Format	Example	Percentage
{first initial}	j@nerai.bio	50%
{first name}	john@nerai.bio	50%

About Nerai Bioscience

Nerai Bio is advancing the frontier of genome editing with a new generation of ultra-precise CRISPR enzymes engineered to unlock genomic targets beyond the reach of existing technologies. Our proprietary MORPHEME platform combines AI and high-throughput protein engineering via directed evolution to design bespoke genome editors with unmatched specificity and therapeutic potential. Our mission is to create a world where no genetic disease is too rare, too hard, or too complex to cure. At Nerai, we don’t just edit DNA—we aim to rewrite the future of patients.

Nerai Bioscience revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	$170,400